BVS logo

Bioventus (BVS)

Profile

Full Name

Bioventus Inc.

Ticker Symbol

BVS

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

February 11, 2021

Indexes

Not included

Website

http://www.bioventus.com

Employees

930

Key Details

Price

$7.48(-1.19%)

Market cap

$494.85M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$573.28M(+11.89% YoY)

Annual EPS

-$0.52(+79.12% YoY)

PE ratio

-

Next earnings date

May 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$7.48
BVS price is $7.48

30-Day Relative Volume

0.74
BVS 30-day relative volume is 0.74

Price Performance

Price Most recent change

-1.19%
BVS price was down -1.19% on Apr 11, 2025

Price YTD change

-28.76%
BVS price is down -28.76% since January 1st

Price 1-year change

+55.51%
BVS price is up +55.51% year-on-year

Price 3-year change

-42.02%
BVS price is down -42.02% over the past 3 years

Price Range

Price All-time high

$19.94
BVS price is currently -62.49% below its historical high of $19.94

Price 3-year low

$0.80
BVS price is currently +835.00% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$494.85M
BVS market capitalization is $494.85 million

Market cap 3-year change

-37.48%
BVS market capitalization is down -37.48% over the past 3 years

Market cap All-time high

$996.78M
BVS market capitalization is currently -50.35% below its historical high of $996.78 million

Market cap sector rank

69.76%
BVS market capitalization is higher than 69.76% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+3.9%
BVS shares outstanding is up +3.9% year-on-year

Shares Outstanding 3-Year Change

+7.82%
BVS shares outstanding is up +7.82% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.86
BVS beta is 0.86

200-day SMA

$10.01
BVS price is currently -25.28% below its 200-day simple moving average

50-day SMA

$9.71
BVS price is currently -22.96% below its 50-day simple moving average

RSI

30.22
BVS 14-day relative strength index is 30.22

Volume

0.74
BVS 30-day relative volume is 0.74

ATR

$0.65
BVS average true range is $0.65

10-day Historical Volatility

68.81%
BVS 10-day historical volatility is 68.81%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$573.28M
BVS annual revenue is $573.28 million

Revenue Analysts estimate

$564.86M
BVS annual revenue is currently +1.49% higher than the consensus analysts' forecast

Revenue 1-year change

+11.89%
BVS annual revenue is up +11.89% year-on-year

Revenue Sector rank

75.03%
BVS annual revenue is higher than 75.03% of companies in Healthcare sector

EPS

EPS

-$0.52
BVS annual earnings per share is -$0.52

EPS Analysts estimate

$0.66
BVS annual earnings per share is currently -179.38% lower than the consensus analysts' forecast

EPS 1-year change

+79.12%
BVS annual earnings per share is up +79.12% year-on-year

EPS Sector rank

68.04%
BVS annual earnings per share is higher than 68.04% of companies in Healthcare sector

Profit

Gross profit

$388.23M
BVS annual gross profit is $388.23 million

Gross margin

67.72%
BVS annual gross profit margin is 67.72%

Operating profit

$26.04M
BVS annual operating income is $26.04 million

Operating margin

4.54%
BVS annual operating profit margin is 4.54%

Net income

-$33.54M
BVS annual net profit is -$33.54 million

Net margin

-5.85%
BVS annual net profit margin is -5.85%

Expenses

Total expenses

$547.24M
BVS annual total expenses is $547.24 million

Operating expenses

$362.19M
BVS annual total operating expenses is $362.19 million

Cost of goods sold

$185.05M
BVS annual cost of goods sold is $185.05 million

Selling, general & administrative expenses

$340.89M
BVS annual SGA is $340.89 million

Depreciation and amortization

$49.55M
BVS annual depreciation & amortization is $49.55 million

Interest expense

$38.79M
BVS annual interest expense is $38.79 million

Income tax

-$5.29M
BVS annual income tax is -$5.29 million

EBIT & EBITDA

EBIT

-$10.33M
BVS annual earnings before interest & taxes is -$10.33 million

EBITDA

$39.22M
BVS annual EBITDA is $39.22 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$727.96M
BVS annual total assets is $727.96 million

Non current assets

$452.35M
BVS annual long term assets is $452.35 million

Current assets

$275.61M
BVS annual total current assets is $275.61 million

Cash and cash equivalents

$41.58M
BVS annual cash & cash equivalents is $41.58 million

Accounts receivable

$127.39M
BVS annual accounts receivable is $127.39 million

Inventory

$92.47M
BVS annual inventory is $92.47 million

Liabilities

Total liabilities

$542.35M
BVS annual total liabilities is $542.35 million

Long term liabilities

$331.95M
BVS annual total long term liabilities is $331.95 million

Current liabilities

$210.40M
BVS annual total current liabilities is $210.40 million

Accounts payable

$23.69M
BVS annual accounts payable is $23.69 million

Debt

Total debt

$335.63M
BVS annual total debt is $335.63 million

Total debt 1-year change

-15%
BVS annual total debt is down -15% year-on-year

Long term debt

$308.29M
BVS annual long term debt is $308.29 million

Short term debt

$27.34M
BVS annual short term debt is $27.34 million

Equity & Capital

Shareholders equity

$147.94M
BVS annual stockholders equity is $147.94 million

Book value

$147.94M
BVS annual book value is $147.94 million

Retained earnings

-$355.08M
BVS annual retained earnings is -$355.08 million

Working capital

$65.21M
BVS annual working capital is $65.21 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$38.80M
BVS annual cash flow from operations is $38.80 million

Cash from operations 1-year change

+152.83%
BVS annual cash flow from operations is up +152.83% year-on-year

Cash from investing

$22.96M
BVS annual cash flow from investing activities is $22.96 million

Cash from investing 1-year change

+45.27%
BVS annual cash flow from investing activities is up +45.27% year-on-year

Cash from financing

-$54.58M
BVS annual cash flow from financing activities is -$54.58 million

Cash from financing 1-year change

-104.78%
BVS annual cash flow from financing activities is down -104.78% year-on-year

CAPEX

CAPEX

$1.01M
BVS annual capital expenditures is $1.01 million

CAPEX 1-year change

-86.34%
BVS annual capital expenditures is down -86.34% year-on-year

Free Cash Flow

Free cash flow

$37.79M
BVS annual free cash flow is $37.79 million

Free cash flow 1-year change

+373.43%
BVS annual free cash flow is up +373.43% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

67.72%
BVS annual gross profit margin is 67.72%

Operating margin

4.54%
BVS annual operating profit margin is 4.54%

Net margin

-5.85%
BVS annual net profit margin is -5.85%

ROA & ROE

ROA

-4.36%
BVS annual return on assets is -4.36%

ROE

-16.49%
BVS annual return on equity is -16.49%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
BVS price to earnings ratio value is unknown

PE ratio Sector rank

-
BVS price to earnings ratio is unknown

PB Ratio

PB ratio

3.34
BVS price to book ratio is 3.34

PB ratio Sector rank

74.92%
BVS price to book ratio is higher than 74.92% of companies in Healthcare sector

PS Ratio

PS ratio

0.86
BVS price to sales ratio is 0.86

PS ratio Sector rank

25.38%
BVS price to sales ratio is higher than 25.38% of companies in Healthcare sector

Enterprise value

Enterprise value

$788.90M
BVS enterprise value is $788.90 million

Enterprise value Sector rank

74.28%
BVS enterprise value is higher than 74.28% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

20.11
BVS EV/EBITDA is 20.11

EV/EBITDA Sector rank

91.75%
BVS EV/EBITDA is higher than 91.75% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.31
BVS annual current ratio is 1.31

Quick ratio

0.87
BVS annual quick ratio is 0.87

Leverage

Debt to equity

2.27
BVS annual debt to equity ratio is 2.27

Interest coverage ratio

-0.27
BVS annual interest coverage ratio is -0.27

Risk & Stability

Piotroski F-Score

5
BVS piotroski f-score is 5

Altman Z-Score

0.71
BVS altman z-score is 0.71

Analyst ratings

Recent major analysts updates

Mar 17, 25 Canaccord Genuity
Buy
Dec 17, 24 JP Morgan
Neutral
Nov 6, 24 Canaccord Genuity
Buy
Sep 27, 24 Craig-Hallum
Buy
Aug 13, 24 Canaccord Genuity
Buy
Aug 7, 24 Craig-Hallum
Buy
May 8, 24 Canaccord Genuity
Buy
Mar 13, 24 Craig-Hallum
Buy
Dec 7, 23 Canaccord Genuity
Buy
Apr 3, 23 Craig-Hallum
Hold

Institutional Ownership

Similar stocks

KROS logo
Keros Therapeutics (KROS)
Auna SA (AUNA)
TLRY logo
Tilray Brands (TLRY)
IMTX logo
Immatics NV (IMTX)
SVRA logo
Savara (SVRA)
COGT logo
Cogent Biosciences (COGT)
QURE logo
uniQure NV (QURE)
VALN logo
Valneva SE (VALN)
ARVN logo
Arvinas (ARVN)
  • What is the ticker symbol for Bioventus?
  • Does Bioventus pay dividends?
  • What sector is Bioventus in?
  • What industry is Bioventus in?
  • What country is Bioventus based in?
  • When did Bioventus go public?
  • Is Bioventus in the S&P 500?
  • Is Bioventus in the NASDAQ 100?
  • Is Bioventus in the Dow Jones?
  • When was Bioventus's last earnings report?
  • When does Bioventus report earnings?
  • Should I buy Bioventus stock now?

What is the ticker symbol for Bioventus?

The ticker symbol for Bioventus is NASDAQ:BVS

Does Bioventus pay dividends?

No, Bioventus does not pay dividends

What sector is Bioventus in?

Bioventus is in the Healthcare sector

What industry is Bioventus in?

Bioventus is in the Medical Devices industry

What country is Bioventus based in?

Bioventus is headquartered in United States

When did Bioventus go public?

Bioventus's initial public offering (IPO) was on February 11, 2021

Is Bioventus in the S&P 500?

No, Bioventus is not included in the S&P 500 index

Is Bioventus in the NASDAQ 100?

No, Bioventus is not included in the NASDAQ 100 index

Is Bioventus in the Dow Jones?

No, Bioventus is not included in the Dow Jones index

When was Bioventus's last earnings report?

Bioventus's most recent earnings report was on Mar 11, 2025

When does Bioventus report earnings?

The next expected earnings date for Bioventus is May 7, 2025

Should I buy Bioventus stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page